In situ analyses of genome instability in breast cancer
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of genome instability and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS)145.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [145]
In the citing paper
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [353]
In the citing paper
“telomeres were shown to be shorter in invasive cancers Telomeres and telomerase in cancer of the breast, prostate and pancreas, as well as in their pre-invasive counterparts (123-126).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [124]
In the citing paper
“Recent observations indicate that both telomere dysfunction73, 74 and the DDR75, 76 are activated at the earliest stages in many human carcinomas.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [73]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829 · cited 1×
“This may explain why the risk of developing invasive cancer in individuals with UDH is only modestly increase”
BackgroundTelomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999 · cited 1×
“We analyzed genome copy-number changes using array CGH as described previousl”
MethodSelf-citationRegulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798 · cited 1×
“Most epithelial cells lack active telomerase, and so extended proliferation leads to telomere erosion and, eventually, loss of telomere functio”
BackgroundConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · cited 1×
“The molecular events that enable normal epithelial cells to progress to invasive, metastatic disease are increasingly well understoo”
BackgroundNormal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Self-citationERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Self-citationTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“and are almost always eliminated by damage-surveillance mechanism”
BackgroundKuukasjärvi, T., Karhu, R., Tanner, M., Kähkönen, M., Schäffer, A. A., Nupponen, N. N., Pennanen, S., Kallioniemi, A. H., Kallioniemi, O., & Isola, J. (1997) · PubMed · Cited by 401
Stem cells and breast cancer: A field in transit
Smalley, M., & Ashworth, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1212 · Cited by 380 · cited 1×
“This post-transition immortal cell and its progeny would have the features ascribed to tumor stem cell”
BackgroundFully Automatic Quantification of Microarray Image Data
Jain, A. N., Tokuyasu, T. A., Snijders, A. M., Segraves, R., Albertson, D. G., & Pinkel, D. (2002) · Genome Research · doi:10.1101/gr.210902 · Cited by 342 · cited 1×
“We acquired DAPI, Cy3 and Cy5 images using a CCD camera system and analyzed them as describe”
MethodAnalysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340 · cited 1×
“First, the total number of aberrations typically is much higher in DCIS than in UD”
Background(2003) · PubMed · Cited by 313
Self-citationIsola, J. J., Kallioniemi, O., Chu, L. W., Fuqua, S. A. W., Hilsenbeck, S. G., Osborne, C. K., & Waldman, F. M. (1995) · Europe PMC (PubMed Central) · Cited by 298
Telomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246
Nishizaki, T., DeVries, S., Chew, K., Goodson, W. H., Ljung, B., Thor, A. D., & Waldman, F. M. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199708)19:4<250::aid-gcc7>3.0.co;2-w · Cited by 184
Self-citationNishizaki, T., DeVries, S., Chew, K., Goodson, W. H., Ljung, B., Thor, A. D., & Waldman, F. M. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199708)19:4<267::aid-gcc9>3.0.co;2-v · Cited by 181
Self-citationChromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences
Waldman, F. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.4.313 · Cited by 164 · cited 1×
“Few genome aberrations were apparent before transition, as observed in UDH; the number increased sharply shortly after telomere crisis, as found in DCIS; and the number changed slowly thereafter, as found for invasive cance”
BackgroundSegmentation of confocal microscope images of cell nuclei in thick tissue sections
ORTIZ DE SOLÓRZANO, C., GARCÍA RODRIGUEZ, E., JONES, A., PINKEL, D., GRAY, J. W., SUDAR, D., & LOCKETT, S. J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00463.x · Cited by 156
Self-citationMeeker, A. K., Hicks, J. L., Gabrielson, E., Strauss, W. M., De Marzo, A. M., & Argani, P. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63180-x · Cited by 140
Kim, M. M., Rivera, M. A., Botchkina, I. L., Shalaby, R., Thor, A. D., & Blackburn, E. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131211098 · Cited by 138
Online Access to CGH Data of DNA Sequence Copy Number Changes
Knuutila, S., Autio, K., & Aalto, Y. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64579-8 · Cited by 137 · cited 1×
“Many of the aberrations detected in post-crisis HMECs involved regions that are recurrently aberrant in primary tumor”
BackgroundNonet, G. H., Stampfer, M. R., Chin, K., Gray, J. W., Collins, C. C., & Yaswen, P. (2001) · PubMed · Cited by 135
Self-citationThe Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis
Takimoto, R., Wang, W., Dicker, D. T., Rastinejad, F., Lyssikatos, J., & El-Deiry, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.41 · Cited by 128
Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.
Kuukasjärvi, T., Tanner, M., Pennanen, S., Karhu, R., Kallioniemi, O., & Isola, J. J. (1997) · Europe PMC (PubMed Central) · Cited by 101
Herbert, B.-S., Wright, W. E., & Shay, J. W. (2001) · Breast Cancer Research · doi:10.1186/bcr288 · Cited by 88 · cited 1×
“and reactivation of telomerase occurs during transition from UDH to DCI”
BackgroundYashima, K., Milchgrub, S., Gollahon, L., Maitra, A., Saboorian, M. H., Shay, J. W., & Gazdar, A. F. (1998) · PubMed · Cited by 87
Thompson, C. T., LeBoit, P. E., Nederlof, P. M., & Gray, J. W. (1994) · PubMed Central · Cited by 69
Self-citationTelomerase: biology and phase I trials
Kèlland, L. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00226-6 · Cited by 47
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
“Circumstantial support for the importance of transient telomere deficiency in facilitating malignant progression has come, in addition, from comparative analyses of premalignant and malignant lesions in the human breast (Raynaud et al., 2010; Chin et al., 2004).”
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
“Despite the myriad of mutations and changes in the genome, the majority of which are identical to those in the frank tumor”
BackgroundGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
“…copy number changes in the ZNF217-transfected human mammary epithelial cells that emerged after passage through telomere crisis having achieved clonal dominance in the culture (Chin et al., 2004; see Figure S2)—presumably because the aberrations they carried conferred a proliferative advantage.”
Self-citation
Metadata
- Authors
- Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., Miranda, M., Krig, S., Garbe, J., Stampfer, M., Yaswen, P., Gray, J. W., & Lockett, S. J.
- Affiliations
- University of California, San Francisco (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Gray, Joe W
- Venue
- Nature Genetics
- Published
- 2004-08-08
- Volume
- 36
- Issue
- 9
- Pages
- 984-988
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2053300345
- Semantic Scholar
- 005930a6472117d3d08d09415087ec01d5c8ecb1
- Cited by
- 361
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 17 · 2017: 15 · 2016: 19 · 2015: 19 · 2014: 14 · 2013: 24 · 2012: 24
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- U.S. Department of Health and Human Services
- Avon Foundation for Women
- Universiteit Leiden
- National Institutes of Health
- National Cancer Institute (R01CA101359, R01CA090421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- genomic instability, telomere crisis, breast cancer progression, ductal carcinoma in situ, usual ductal hyperplasia, mammary epithelial cells, ZNF217, cell immortalization, fluorescence in situ hybridization
- MeSH terms
- Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Humans, Hyperplasia, Tumor Cells, Cultured, Ultrasonography, Telomere, In Situ Hybridization, Carcinoma, Ductal, Breast, Disease Progression, Chromosomal Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.